[go: up one dir, main page]

AU4787593A - Heterocyclic derivatives useful in the treatment of cardiovascular diseases - Google Patents

Heterocyclic derivatives useful in the treatment of cardiovascular diseases

Info

Publication number
AU4787593A
AU4787593A AU47875/93A AU4787593A AU4787593A AU 4787593 A AU4787593 A AU 4787593A AU 47875/93 A AU47875/93 A AU 47875/93A AU 4787593 A AU4787593 A AU 4787593A AU 4787593 A AU4787593 A AU 4787593A
Authority
AU
Australia
Prior art keywords
treatment
cardiovascular diseases
derivatives useful
heterocyclic derivatives
heterocyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU47875/93A
Inventor
Dominique Blondet
Jean-Claude Pascal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Publication of AU4787593A publication Critical patent/AU4787593A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/02—1,2-Thiazines; Hydrogenated 1,2-thiazines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU47875/93A 1992-07-31 1993-07-30 Heterocyclic derivatives useful in the treatment of cardiovascular diseases Abandoned AU4787593A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91769892A 1992-07-31 1992-07-31
US917698 1992-07-31
PCT/US1993/007050 WO1994003425A2 (en) 1992-07-31 1993-07-30 Carbostyril derivatives for the treatment of arrhythmia

Publications (1)

Publication Number Publication Date
AU4787593A true AU4787593A (en) 1994-03-03

Family

ID=25439188

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47875/93A Abandoned AU4787593A (en) 1992-07-31 1993-07-30 Heterocyclic derivatives useful in the treatment of cardiovascular diseases

Country Status (4)

Country Link
AU (1) AU4787593A (en)
IL (1) IL106549A0 (en)
MX (1) MX9304626A (en)
WO (1) WO1994003425A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5451677A (en) * 1993-02-09 1995-09-19 Merck & Co., Inc. Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity
JPH09502166A (en) * 1993-07-31 1997-03-04 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 2-Benzoheterocyclyloxy or thiopropanolamine derivatives having adrenergic receptor agonist activity
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
US5817690A (en) * 1996-08-27 1998-10-06 American Home Products Corporation 4-aminoethoxy indolone derivatives
KR20000035818A (en) * 1996-08-27 2000-06-26 이곤 이 버그 4-aminoethoxy indolone derivatives
US5808080A (en) * 1996-09-05 1998-09-15 Eli Lilly And Company Selective β3 adrenergic agonists
ES2171839T3 (en) * 1996-09-05 2002-09-16 Lilly Co Eli CARBAZOL ANALOGS AS BETA3 SELECTIVE ADRENERGIC AGONISTS.
JP2001525398A (en) * 1997-12-05 2001-12-11 イーライ・リリー・アンド・カンパニー Selective β3 adrenergic agonist
CO5011072A1 (en) 1997-12-05 2001-02-28 Lilly Co Eli ETANOLAMINAS PIRAZINIL SUBSTITUTED AS AGFONISTS OF THE RECEPTORS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
DE3310891A1 (en) * 1983-03-25 1984-09-27 Boehringer Mannheim Gmbh, 6800 Mannheim NEW INDOLINON (2) DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND INTERMEDIATE PRODUCTS
EG18188A (en) * 1986-05-01 1992-09-30 Pfizer Ltd Process for preparation anti-arhythmia agents
US5082847A (en) * 1990-07-18 1992-01-21 Syntex (U.S.A.) Inc. Carbostyril compounds connected via an oxyalkyl group with a piperidine ring and having pharmaceutical utility

Also Published As

Publication number Publication date
WO1994003425A3 (en) 1994-03-31
WO1994003425A2 (en) 1994-02-17
MX9304626A (en) 1994-02-28
IL106549A0 (en) 1993-12-08

Similar Documents

Publication Publication Date Title
AU6566094A (en) Heterocyclic derivatives in the treatment of ischaemia and related diseases
AU3548795A (en) Benzopyranopyrazolyl derivatives for the treatment of inflammation
PL313619A1 (en) Derivatives of piperydine
AU662997B2 (en) Condensed heterocyclic derivative and weedkiller
PL310443A1 (en) Derivatives of pyrolo-pyridine
AU3959193A (en) Heterocyclic compounds and their use in the treatment of type II-diabetes
AU643494B2 (en) 4-Isoxazole carboxamide derivatives
PL306127A1 (en) Derivatives of epi-epibathydine
AU3039995A (en) Heterocyclic derivatives of N-phenylamides
AU4357296A (en) Benzene-fused heterocyclic derivatives and use of the same
AU8107694A (en) Use of substituted thiazolidine derivatives in the treatment of raised intraocular pressure
AU2490492A (en) Process for the preparation of beta-phenylisoserine derivatives and use thereof
ZA984174B (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases
AU4787593A (en) Heterocyclic derivatives useful in the treatment of cardiovascular diseases
AU3195993A (en) Heterocyclic derivatives
GB9517043D0 (en) The use of bile acid derivatives
IL133089A0 (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases
AU1028892A (en) Phenoxyalkylcarboxylic acid derivatives and process of preparing the same
AU4812393A (en) Use of rapamycin in the treatment of aids
AU2705495A (en) Use of rooperol and hypoxoside and their derivatives in the treatment of inflammatory
AU4096789A (en) The use of lactam derivatives in the treatment of cognitive disorders
AU4319393A (en) Use of indolocarbazols in aids treatment
AU1485197A (en) Diamines in the treatment of arrhythmia
AU5572594A (en) Arylamino-alkoximino derivatives and their use as fungicides
AU5158493A (en) Treatment of corn with expander